These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 22197974

  • 1. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.
    Semenova VA, Schiffer J, Steward-Clark E, Soroka S, Schmidt DS, Brawner MM, Lyde F, Thompson R, Brown N, Foster L, Fox S, Patel N, Freeman AE, Quinn CP.
    J Immunol Methods; 2012 Feb 28; 376(1-2):97-107. PubMed ID: 22197974
    [Abstract] [Full Text] [Related]

  • 2. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
    Li H, Soroka SD, Taylor TH, Stamey KL, Stinson KW, Freeman AE, Abramson DR, Desai R, Cronin LX, Oxford JW, Caba J, Pleatman C, Pathak S, Schmidt DS, Semenova VA, Martin SK, Wilkins PP, Quinn CP.
    J Immunol Methods; 2008 Apr 20; 333(1-2):89-106. PubMed ID: 18304568
    [Abstract] [Full Text] [Related]

  • 3. Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax.
    Ghosh N, Gunti D, Lukka H, Reddy BR, Padmaja J, Goel AK.
    Indian J Med Res; 2015 Aug 20; 142(2):196-204. PubMed ID: 26354217
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials.
    Soroka SD, Schiffer JM, Semenova VA, Li H, Foster L, Quinn CP.
    Biologicals; 2010 Nov 20; 38(6):675-83. PubMed ID: 20875951
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice.
    Sloat BR, Cui Z.
    J Pharm Pharmacol; 2006 Apr 20; 58(4):439-47. PubMed ID: 16597361
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine.
    Lininger LA, Cullum ME, Lyles MB, Bienek DR.
    Vaccine; 2007 Feb 19; 25(9):1619-25. PubMed ID: 17150286
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Validation of an anti-PA-ELISA for the potency testing of anthrax vaccine in mice.
    Pombo M, Berthold I, Gingrich E, Jaramillo M, Leef M, Sirota L, Hsu H, Arciniega J.
    Biologicals; 2004 Sep 19; 32(3):157-63. PubMed ID: 15536047
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Validation of high throughput screening of human sera for detection of anti-PA IgG by Enzyme-Linked Immunosorbent Assay (ELISA) as an emergency response to an anthrax incident.
    Semenova VA, Steward-Clark E, Maniatis P, Epperson M, Sabnis A, Schiffer J.
    Biologicals; 2017 Jan 19; 45():61-68. PubMed ID: 27814939
    [Abstract] [Full Text] [Related]

  • 19. Anthrax vaccine adsorbed: further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed.
    Pittman PR, Cavicchia MA, Kingsbury JL, Johnson NA, Barrera-Oro JG, Schmader T, Korman L, Quinn X, Ranadive M.
    Vaccine; 2014 Sep 03; 32(39):5131-9. PubMed ID: 24837771
    [Abstract] [Full Text] [Related]

  • 20. Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed anthrax vaccine.
    Bienek DR, Chang CK, Cohen ME.
    Vaccine; 2007 Aug 10; 25(32):5978-84. PubMed ID: 17597265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.